Abstract. Neocortical neuroblast cell lines were used to clone G-protein-coupled receptor (GPCR) genes to study signaling mechanisms regulating cortical neurogenesis. One putative GPCR gene displayed an in situ expression pattern enriched in cortical neurogenic regions and was therefore named ventricular zone gene-! (vzg-1). The vzg-1 cDNA hybridized to a 3.8-kb mRNA transcript and encoded a protein with a predicted molecular mass of 41--42 kD, confirmed by Western blot analysis. To assess its function, vzg-1 was overexpressed in a cell line from which it was cloned, inducing serum-dependent "cell rounding." Lysophosphatidic acid (LPA), a bioactive lipid present in high concentrations in serum, reproduced the effect seen with serum alone. Morphological responses to other related phospholipids or to thrombin, another agent that induces cell rounding through a GPCR, were not observed in vzg-1 overexpressing cells. Vzg-1 overexpression decreased the EC50 of both cell rounding and Gi activation in response to LPA. Pertussis toxin treatment inhibited vzg-l-dependent LPA-mediated Gi activation, but had no effect on cell rounding. Membrane binding studies indicated that vzg-1 overexpression increased specific LPA binding. These analyses identify the vzg-1 gene product as a receptor for LPA, suggesting the operation of LPA signaling mechanisms in cortical neurogenesis. Vzg-1 therefore provides a link between extracellular LPA and the activation of LPAmediated signaling pathways through a single receptor and will allow new investigations into LPA signaling both in neural and nonneural systems.
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CRITICAL event in the formation of the mammalian cerebral cortex is the ordered generation of its neurons from a discrete proliferative region overlying the cerebral ventricles, the ventricular zone (vz) t (6), (Fig. 1) . In most mammalian species, neurogenesis occurs during fetal life when the vz can be delineated by histological stains, or by brief pulses of 5-Bromo-2'-deoxyuridine (BrdU) or [3H]thymidine, which identify neuroblasts undergoing S-phase (58, 64, 67) . Cortical neuroblasts display a stereotyped change in their morphology that is linked to their proliferation. During S-phase of the cell cycle, vz neuroblasts appear bipolar, with the cell body at the super-ficial margin of the vz and with processes oriented towards the ventricular and superficial (pial) surfaces of the cerebral wall. With the progression of the cell cycle, the neuroblast undergoes "interkinetic nuclear migration" whereby its nucleus descends to the ventricular surface during G2, its pial process is retracted, and the cell "rounds up" (62, 63) . After rounding, the cell undergoes mitosis and then regains its bipolar morphology to complete the cell cycle ( Fig. 1 a) . In the mouse, cortical neurogenesis is limited to the period between embryonic day 11 (Ell) and El8 (9, 10, 67) . Beyond this period, cells are still produced within the cerebral wall; however, these cells are generally of glial rather than neuronal lineages (4, 10, 22, 32, 67) .
The molecular mechanisms responsible for controlling vz neurogenesis are largely unknown. However, three observations suggest that it is regulated, at least in part, by interactions between a neuroblast and its environment, rather than through cell-autonomous mechanisms. First, a number of growth factors operating through receptor tyrosine kinases (RTKs) (3, 78) , most notably basic fibroblast growth factor, promote proliferation of telencephalic cells in primary culture (8, 30, 44, 70) . Second, uncharacterized serum factors appear to be required in addition to mRNA colocalizes with cortical neuroblast proliferation. Cortical neuroblasts were labeled with a 1-h pulse of BrdU (brown reaction product) to identify cells undergoing DNA synthesis (58, 68) . Vzg-1 expression was localized in the same section by in situ hybridization of an antisense digoxigenin-labeled vzg-1 riboprobe visualized by immunohistochemistry (purple reaction product). Note that vzg-1 expression is limited to the proliferative zone defined by BrdU labeling. Arrows delineate upper limit of the CNS. Bar, 50 ~m.
identified growth factors to promote cortical cell proliferation (43, 44) , consistent with normal cortical development in mice with null mutations for known growth factors and/ or their receptors (45) . Third, cell membranes or cell--cell contacts also promote proliferation of telencephalic blasts (30, 69) . These observations could be explained by the operation of novel receptors, distinct from RTKs, regulating cortical neurogenesis.
An attractive candidate for this role is the G-proteincoupled-receptor (GPCR) family. It is crucial to central nervous system (CNS) function (20) and contains many diverse members (7, 57) , some of which have known mitogenic effects (1, 41, 74) . To isolate GPCR genes, we used novel clonal cell lines derived from the vz that resemble cortical neuroblasts (14) . These cell lines provide a unique source of cDNA for cloning strategies and can further be used for functional studies of receptor genes, enabling an identified receptor to interact with signaling pathways approximating those found in vivo.
Here we report the complete sequence and developmental CNS expression pattern of a new member of the GPCR family named ventricular zone gene-1 (vzg-1) because of its restricted expression within the cerebral cortical vz (Fig. i b) . Based on functional assays, ligand binding data, and its tissue distribution, we conclude that vzg-1 encodes a receptor for lysophosphatidic acid (LPA). LPA is a phospholipid signaling molecule that has a wide variety of effects on many different cell types (see Discussion; for recent reviews see 26 and 54) . Although LPA almost certainly acts through a GPCR, a cDNA clone of this receptor has not been identified, in part reflecting the chemical characteristics of LPA that result in unacceptably high levels of nonspecific binding, making techniques such as expression cloning impractical. Therefore, the possibility that nonreceptor mechanisms could account for observed effects of LPA has been left open ( 26, 71, 74, 77) . To overcome these difficulties, we have instead relied on welldefined functional characteristics of LPA signal transduction to identify the vzg-1 gene product as a receptor for LPA.
Materials and Methods

Cell Culture
Cell lines TSM and TR (14) were grown in OptiMEM f (GIBCO BRL, Gaithersburg, MD) with 5% FCS (Hyclone Labs, Logan, UT), 20 mM glucose, 55 ~zM 2-mercaptoethanol, 1013 U/ml penicillin, and 100 lxg/ml streptomycin at 37°C, 5% CO2.
Cell Transfection. Transient transfection used calcium phosphate precipitation (12) with a 10:1 molar ratio of vzg-1 expression plasmid to 13-galactosidase expression plasmid pCMVJ~ (Clonetech, Palo Alto, CA). After 18 h, cells were refed, grown for 24 h, fixed in 4% paraformaldehyde in PBS for 10 min, and stained for 13-galactosidase activity (2) . Positive cells (200/ plate) were counted "blind." The statistical program Instat (Graphpad Software, San Diego, CA) was used for one-way analysis of variance and the Student-Newman-Keuls pairwise t-test. Stable transfection used a 10:1 molar ratio of vzg-1 expression plasmid to pSV2-puro (79) and selection in medium containing 10 I~g/ml puromycin. After 2 wks of selection, single colonies of cells were picked using cloning cylinders, expanded, and then stored or processed for RNA isolation and Northern analyses as previously described (14, 19) .
Morphological Assay. Stable cell lines (5,000/well in 24-well plates) were serum starved for 24 h, and then media containing the desired agents was added to the required final concentration. Cells were fixed in 4% paraformaldehyde in PBS to terminate incubation and examined. Experiments were performed in duplicate (200 cells counted/well) and representative samples were evaluated by multiple investigators. Statistical methods used were identical to transient experiments.
cAMP Assay. Cells (30,000) were plated, serum starved overnight, and then stimulated for 7 min at 37°C with serum-free medium containing 200 /xM 3-isobutyl-l-methylxanthine, 10 ~M isoproterenol, and LPA. cAMP accumulation was measured as described (55) . Data were analyzed using Prism (Graphpad Software).
Pertussis Toxin (PTX) Treatment. Ceils were treated with 200 ng/ml PTX for 16 h, followed by a 3-h treatment with fresh PTX.
Molecular Biological Techniques
PCR Amplification of GPCR Family Members. Poly-A+ RNA was isolated from TR and TSM cells (twice selected on oligo-dT cellulose |Pharmacia LKB Biotechnology, Piscataway, NJ]) (2) and 10.5 trg of RNA was reverse transcribed using oligo-dT or random hexamer primers in 50 mM Tris, pH 8.3, 6 mM MgCI2, 40 mM KC1, 1 mM DTr, 1 mM each dNTPs, and 10 U/Ixl Moloney murine leukemia virus reverse transcriptase (GIBCO BRL). RNA and primers were heated to 65°C (5 min), then cooled to room temperature (RT). Additional reagents were added, and then heated to 37°C (2 h). This cDNA was PCR amplified using a degenerate primer set derived from the conserved regions of transmembrane (TM) domain If and VII of the GPCR family (7) . PCR reactions used 40 ng of eDNA in 10 mM Tris, pH 8.3, 50 mM KCI, 2 tLM of each primer, 1.5 mM MgCI2, 0.2 I~M each dNTPs, and 2.5 U Taq DNA polymerase. All 30 pairwise combinations of primers were used. Reactions were placed in a Perkin-Elmer 480 thermal cycler (Applied Biosystems, Inc., Foster City, CA) at 94°C (3 min) and then cycled 25-40 times at 96°C (45 s), 47°C (144 s) or 53°C (216 s), and 72°C (3 min, 6 s extension/cycle). Products were T/A cloned (53) , screened by in situ hybridization, and sequenced. The product used to clone vzg-1 ("513") was independently isolated using TM II 
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Full-Length Vzg-1 cDNA Cloning. Clone "513" was used to screen 500,000 phage plaques at high stringency from a postnatal day 20 BALB/c (same strain as cell lines TR and TSM) mouse brain library (Stratagene, La Jolla, CA). Clone "pSt3," containing a 2,250-bp insert, was sequenced completely in both directions by the dideoxy chain termination method (2) . Sequence analysis used BLAST (NCBI, Bethesda, MD), MacDNAsis (Hitachi Software, San Bruno, CA), and the GCG programs (Genetics Computer Group, Madison, WI RNA Isolation and Northern Analysis. These methods have been previously described (2, 14, 19) .
Histology
In Situ Hybridization. In situ hybridization to BALB/c mouse embryos was performed as previously described using digoxigenin-labeled riboprobes visualized by alkaline phosphatase histochemistry (19, 73) .
BrdUlIn Situ Hybridization Double Labeling. Timed pregnant BALB/c mice were injected intraperitoneally with 20 i~l I0 mM BrdU/g body weight 1 h before sacrifice. In situ hybridization and probe visualization were immediately followed by HCI incubation (60~C in 1 N HC1,15 rain), and slides were washed in PBS (RT, 10 rain, 3×), incubated in blocking solution (RT, 2.5% BSA, 0.3% Triton X-100, 1× PBS, 1 h), and then incubated in 6 }xg/ml mouse monoclonal anti-BrdU antibody (RT, 1 h) (Boehringer-Mannheim Corp., Indianapolis, IN). Bound antibody was visualized by anti-mouse Vectastain ABC peroxidase kit (Vector Laboratories, Burlingame, CA) as previously described (15) (16) (17) (18) . 
Phospholipid Sources and Receptor-Ligand Binding
Lipids (1-oleoyMysophosphatidylethanolamine [LPE], 1-oleoyl-lysophos- phatidylglycerol [LPG], 1-oleoyl-lysophosphatidylcholine [LPC], 1, 2-dio- leoyl-phosphatidic
Membrane Isolation and [3H]LPA Binding Assay. Cell lines were grown
to 90% confluence, washed with PBS, scraped from the plate, centrifuged for 5 rain (110 g), washed with PBS, recentrifuged, and the pellet then resuspended in 10 ml of ice-cold 20 mM Tris, pH 7.5, disrupted by 20 strokes in a glass homogenizer, and sonicated on ice with three 10-s bursts using a microultrasonic cell disrupter (Kontes Glass, Hayward, CA). After low speed centrifugation (1,000 g, 15 min, 4°C), membranes were pelleted from the supernatant (16,000 g, 30 rain, 4°C), and resuspended at 3 p,g/p,l protein in ice-cold 20 mM Tris, pH 7.5. Just before analysis, membranes were resonicated for 5 s on ice until the solution became transparent, then LPA binding assays carried out as previously described (71) . Briefly, binding reactions (500 ixl of 50 ixg/ml membrane protein in an assay buffer of 20 mM riffs, pH 7.5, and 0.5 mM CuSO4) were initiated by addition of l-oleoyI-[9,10-SH]-LPA (56.2 Ci/mmol) to a final concentration of 8.5 nM (230,000 cpm) and incubated (30°C, 30 min). To assess nonspecific binding, 2 p~M unlabeled 1-oleoyl-LPA was added to a set of parallel reactions. Reactions were run through PD-10 Sephadex G25M columns (Pharmacia LKB Biotechnology) to separate bound from free ligand. The eluent (1.5 ml) was mixed with scintillation fluid (Ultima Gold; Packard Instrument Co., Inc., Meriden, CT) and counted at RT. About 5-10% of the total input cpm were collected in the eluent. Uncorrected total binding ranged from 13,000 to 20,000 cpm. Because LPA forms aggregates that are excluded from the column bed and thus collected in the eluent, each experiment was performed in parallel using reactions without membranes, in the presence or absence of 2 IxM LPA, to determine eluted background cpm. Total and nonspecific cpm were corrected by subtraction of the appropriate background cpm. Specific cpm were calculated by subtracting corrected nonspecific cpm from corrected total cpm. Overall, with correction, nonspecific cpm were 61% of total clam. Experiments were done in triplicate and the results statistically analyzed using Student's t-test.
Antiserum Production and Western Blot Analysis
A rabbit polyclonal antiserum was raised against Vzg-1 by eDNA vaccination (25, 60) . Twice weekly intradermal injections of vzg-1 expression construct (20 p~g) in PBS for 6 wk were followed by a week hiatus (test bleed) and then injections repeated for 4 wk and serum collected. Cells were se- . Vzg-1 has conserved aa residues shared amongst many members of the GPCR family (v) (57) . Other common features are N-linked glycosylation sites (circled) (24, 59) , cysteine residues that may form disulfide bonds (overlined) (42) , and cysteine residues that can potentially be lipid-modified (,) (80). Multiple serine and threonine residues in the third intracellular loop and COOH-terminal intracellular domain are potential sites for regulatory phosphorylation (31) . These sequence data are available from GenBank/ EMBL/DDBJ under accession number U70622. (b) Kyte-Doolittle hydrophobicity analysis of Vzg-1 (46) reveals seven putative TM domains. Positive values indicate hydrophobicity, while negative values indicate hydrophilicity. The plot was calculated using a window of 15 aa. rum starved 24 h and membranes were prepared as above, except that buffers contained 1 mM EGTA, 1 mM PMSF, and 1 mM benzamidine. Western blot techniques were as previously described (15, 16) . Briefly, membrane proteins were solubilized in 1× sample buffer (2), separated on 15% SDS-PAGE minigels, electroblotted onto nitrocellulose (Scbleicher & Schuell, Inc., Keene, NH), and incubated overnight (RT) with 1: 100 dilution of primary antiserum. Bound antibody was detected using the Vectastain ABC kit (Vector Laboratories, Burlingame, CA) using DAB visualization.
Results
Vzg-1 Encodes a Novel Seven-Transmembrane Domain Molecule
Degenerate oligonucleotide primers against amino acid (aa) sequences from TM II and TM VII of the GPCR family (7, 48) were used in PCR amplification of neocortical cell line cDNA (lines TR and TSM (14) ; Materials and Methods). A total of 154 DNA fragments representing 58 distinct PCR products in the expected size range from 600 to 1,300 bp were cloned. One fragment, "5•3," was localized to the vz (Fig. 1 b) by in situ hybridization and was represented by 13 independently derived clones having GPCR aa sequence homology. Northern blot analysis of embryonic brain detected a single 3.8-kb transcript. Library screening led to isolation of a 2.4-kb cDNA, termed vzg-1, containing an open reading frame (Fig. 2 a) encoding a 41-kD protein with seven hydrophobic membrane spanning domains (Fig. 2 b) , as well as other features of the GPCR family. Comparisons to published sequences (data not shown) demonstrated that Vzg-1 shared homology with the melanocortin receptor (32% aa identity) (23), cannabinoid receptor (30% aa identity) (52) , and the orphan receptor gene edg-1 (37% aa identity) (36) .
Vzg-1 Expression Correlates with Cortical Neurogenesis
The full-length vzg-1 clone hybridized to a transcript iden- tical in size to that identified by fragment 513, which was present in the embryonic mouse brain and in the cell lines from which it was cloned (Fig. 3) . Vzg-1 expression was examined in mouse embryos from El2 to El8 by in situ hybridization. A low magnification view (shown for El4) demonstrated that, within the CNS, vzg-1 expression was highly enriched within the cerebral cortical vz in the dorsal telencephalon. Additional hybridization is observed to a tissue layer closely apposed to CNS, likely to be a developing meningeal layer (Fig. 4, a and b) .
Vzg-1 was expressed throughout most of the cerebral wall at El2, when it consists mainly of proliferative neuroblasts (Fig, 5) . As this wall thickens with further development, vzg-1 expression remained primarily restricted to the proliferative vz ( Fig. 5; see also Fig. i b) . The vzg-1 hybridization signal appeared most intense at E12 and El4, somewhat less at El6, and was barely detectable at El8, Thus, vzg-1 expression is primarily restricted to the vz of the cerebral cortex during neurogenesis.
Vzg-10verexpression Induces Sustained, LPA-dependent Cell Rounding
To determine possible functions of vzg-1, cell line TSM, chosen for its comparatively low expression of the endogenous transcript (Fig. 3) , was transiently transfected with expression vectors containing vzg-1 in the sense or antisense orientation. Transfection with the vzg-1 sense expression vector induced neurite retraction and cell rounding, which was maintained for at least 24 h (Fig. 6 a, "sustained cell rounding"). This morphological change required the presence of serum. Sense transfected cells exposed to serum had 48 + 3.6% round morphology, compared to 22 + 5.0% without serum (Table I) .
The reproducibility of cell rounding allowed its use as a bioassay to identify putative ligands for vzg-1. Boiling the serum did not abolish its ability to mediate cell rounding (data not shown), indicating that the ligand was a heat stable molecule that might be associated with (a) cytoskeletal changes and (b) cell proliferation, since vzg-1 expression was restricted to the vz. A molecule present in serum that met these criteria (see Discussion) was LPA. Since endogenous Vzg-1 should be active in the cell lines from which it was identified, untransfected TSM cells were first assayed for their ability to respond to LPA. Indeed, TSM cells responded with a rapid increase in the percentage of round cells. However, this response was reversible such that by 3 h, the percentages of round cells returned to their baseline values (Fig. 6 b) .
Transfection of TSM cells with vzg-1 in the sense orientation sustained the rounding response to LPA such that at 3 h, 49 +_ 4.9% of treated transfected cells still displayed a round morphology, compared to 29 __ 1.9% of untreated transfected cells (Table I) . Importantly, thrombin, a serum component which also induces cell rounding in some neural cell lines (38, 66), did not induce sustained cell rounding in cells transfected with vzg-1, although it did induce sustained cell rounding in cells transfected with the thrombin receptor (Table II) (Fig. 7 a) . Sense cells, but not empty vector or antisense cells, responded to LPA by sustained cell rounding at 3 h (Fig. 7 b) .
The specificity of the LPA response in vzg-1 sense cells was tested using a range of structurally related phospholipids. Two forms of LPA, 1-oleoyl-LPA and 1-stearoyl-LPA, were examined along with four other structurally related lipids: 1-oleoyl-LPC, 1-oleoyl-LPE, 1-oleoyl-LPG, and 1, 2-dioleoyl-PA (Table III) . Compared to the other phospholipids, only LPA lipids produced sustained cell rounding after 3 h of treatment, and thus the response was specific to LPA.
Vzg-10verexpression Decreases the ECso of LPA-induced Cell Rounding
The cell rounding bioassay was used to determine the effect of LPA concentration on sense, antisense, and empty vector cells. Concentration-response experiments defined the EC50, minimal, and maximal response values of the morphological response to LPA (Fig. 7 c and Table IV) . Sense cells displayed a similar maximal response to LPA as empty vector cells, but were 6.9-fold more sensitive, as demonstrated by a shift in the concentration-response curve to the left. In contrast, antisense cells displayed decreased basal and maximal responses but equal sensitivity 
Vzg-10verexpression Decreases the ECso of LPA-stimulated Gi Activation
To examine whether vzg-1 overexpression altered LPAmediated G i activation, sense, antisense, and empty vector cells were tested for LPA-stimulated inhibition of c A M P accumulation. As shown in Table IV , the ECs0 in sense cells was reduced 6.6-fold relative to empty vector cells. Antisense cells had a similar ECs0 as empty vector cells. The effect of L P A on cAMP accumulation was reversed by PTX treatment, indicating activation of Gi; however, PTX treatment did not affect LPA-induced cell rounding (Table V) . The effect of vzg-1 on LPA-mediated Gi activation was specific to LPA since adenylate cyclase inhibition Ceils were u'ansiently transfected with the indicated expression vectors, followed by treatment with either FCS for 24 h or LPA for 3 h. Data represent the mean + SEM for three to four independent experiments, each done in duplicate. *Indicates statistically significant differences from control conditions ( P < 0.001 ). mediated by UK14304, an a2-adrenergic receptor agonist, did not show differential effects on sense and antisense overexpressing cells (data not shown). 
Vzg-10verexpression Increases LPA Binding in Cell Membranes
Adult Expression of Vzg-1 Parallels Prior Estimates of LPA Receptor Distribution
Prior studies examining the distribution of LPA receptors demonstrated that in adult tissues, receptors are present at very high levels in the brain, are virtually absent from the liver, and are present at intermediate levels in other tissues (71, 77) . Additionally, high levels of receptor are expressed in NIH-3T3 cells. Northern blot analysis (Fig. 8) demonstrated that vzg-1 was expressed at maximal levels in the adult brain, absent from liver, and present at intermediate levels in other tissues, a pattern paralleling these previous results. Vzg-1 was also highly expressed in NIH-3T3 cells (data not shown).
Discussion
LPA Meets Criteria Expected for a Vzg-1 Ligand
Functional analyses of vzg-1 required ligand identification, a difficulty underscored by the huge variety of molecules recognized by the GPCR family (80). Ligand identification was aided by three observations from our study. First, vzg-1 TSM cells were transiently transfected with the indicated expression vectors followed by treatment with either LPA for 3 h or thrombin for 2 h. Data represent the mean -+ SEM for three independent experiments, each done in duplicate. *Indicates statistically significant differences from control conditions (P < 0.001 ).
was highly expressed in the vz, suggesting a function in some aspect of cortical neurogenesis (see below). Second, vzg-l-dependent, serum-induced, sustained cell rounding was highly reproducible, allowing its use as a bioassay. Third, the serum factor inducing cell rounding was heat stable. Prior studies reported that cortical blast proliferation required (a) cell membrane extracts or cell-cell contact (30, 69) and (b) serum (43, 70) . Thus, ligand(s) for Vzg-1 could (a) be involved in cell proliferation or differentiation, (b) promote morphological changes like cell rounding, (c) be heat stable, and (d) be a component of serum or cell membrane extracts.
All of these criteria were met by the bioactive lipid L P A (54). L P A is mitogenic for nonneural cells (72, 75, 81, 82) , produces actin-based stress fiber formation in fibroblasts (61) , and results in the retraction of "neurites" and cell rounding in neuroblastoma-derived cell lines (40) . It is a heat-stable component of serum (61), present at a concentration of 2-20 ~M, that is bound to albumin (27) . It can also be produced from cell membrane phospholipids by phospholipase A2 (29) .
Vzg-1 Has Predicted Properties of a Receptor for LPA
The vzg-1 gene product meets the expected criteria of a receptor for LPA. Vzg-1 encodes a G P C R based on se- Cell lines stably transfected with the vzg-1 sense construct were serum deprived for 24 h, and then treated with 1 I~M concentrations of the indicated phospholipids for 3 h. Data represent the mean -+ SEM for four independent experiments, each done in duplicate. *Indicates statistically significant differences from c0ntrol conditions (P < 0.01 to P < 0.001) quence homology (57) . The ability of this receptor to bind
[3H]LPA was tested using membrane binding assays. Binding studies with LPA are complicated by the lipophilic detergent properties of the radioligand, which favor partitioning into phospholipid bilayers and micelle formation, resulting in substantial levels of nonspecific binding, inefficient separation of bound ligand from free, and high levels of background. As a result of these technical limitations, binding assays cannot be used to make quantitatively rigorous measurements of LPA binding sites, as noted in previous studies (26, 71, 74, 77) . Because of these biophysical properties of LPA and the lack of specific antagonists (77), we cannot pharmacologically characterize LPA interaction with Vzg-1. However, vzg-1 overexpression was associated with a statistically significant increase in specific [3H]LPA membrane binding, a result consistent with the functional characterization of vzg-1 as a receptor for LPA. In TSM neuroblast cell lines overexpressing vzg-1, LPA induced specific, sustained neurite retraction and cell rounding, as reported previously in neuroblastoma cell lines (39) . Neither other phospholipids nor thrombin produced vzg-l-dependent, sustained cell rounding. Characterization of LPA signaling pathways in vzg-I overexpressing cell lines revealed a vzg-l-dependent enhancement of LPA signaling reflected by a decrease in the ECs0 of LPAinduced, Gi-independent cell rounding and Gi-dependent inhibition of cAMP formation, as predicted by previous studies (39, 74) . Based on receptor theory (56) , the increase in potency seen with sense cells is most simply explained by an increase in receptor number, consistent with the increase in protein levels detected by Western blot analysis (Fig. 7 a) . Prior studies on LPA receptor distribution implicated a 38-40-kD protein highly expressed in the adult brain and absent from liver (71, 77 vzg-l-dependent decrease of the ECs0 for Gi-independent LPA-mediated cell rounding, (4) vzg-l-dependent decrease of the ECs0 of LPA-mediated activation of Gi, (5) correspondence between the predicted size of the vzg-1 gene product and prior estimates of LPA receptor size, (6) detection of a gene product of the correct size in brain, with increased levels of expression in sense transfected cells, and (7) correlation between tissue expression of vzg-1 and previous measurements of LPA receptor distribution.
Vzg-1 and LPA Signaling Have Potential Functions in Cortical Neurogenesis
In situ hybridization and BrdU double labeling experiments demonstrate that vzg-1 is expressed within the embryonic vz and is both temporally and spatially related to the period of cortical neurogenesis (67, 68) (Figs. 1 b and  5 ). The identification of the vzg-1 gene product as a receptor for LPA suggests that LPA signaling mechanisms may be important in regulating cortical neurogenesis. Possible Cells were serum deprived for 24 h and then stimulated for 15 min with LPA for cell rounding or for 7 rain for cyclase inhibition. Cell rounding values were calculated from data obtained from three independent experiments, each done in duplicate (c.f. Fig. 7 c) . Cyclase inhibition values were calculated from data obtained from four independent concentration-response experiments, each done in triplicate (data not shown). highly expressed in the adult brain, absent from liver, and present in moderate levels in lung, kidney, and spleen, which correlates strongly with previous estimates of LPA receptor distribution (71, 77) . Variable expression of the ~-actin loading control (cf. Fig. 3 ) reflects documented differences in expression amongst tissues (28) , necessitating use of the 18S rRNA band, visualized with ethidium bromide.
functions of LPA in cortical neurogenesis, based on known bioactivities of LPA and biological events occurring within the vz, include regulation of cytoskeletal events such as interkinetic nuclear movement, cell rounding, and cleavage plane orientation (13, 40) , mitogenesis (discussed below), gap junction regulation (34, 49) , and influence on the binding and assembly of fibronectin (11, 83) , which is expressed in the embryonic cortex (15, 65) . Additionally, regulation of apoptosis, recently shown to occur in the vz (5), may also be influenced by LPA signaling (47) . The actual roles of LPA signaling in the vz, mediated through vzg-1, and the source of endogenous ligand remain to be determined.
Vzg-1 Expression Implicates Distinct GPCR-mediated Signaling Pathways in Cortical Neurogenesis
The major signal transduction elements currently implicated in cortical neurogenesis operate through peptide ligand stimulation of the RTK pathway (70) . By contrast, the bioactive lipid LPA operates through Vzg-1, a GPCR family member. Prior studies on LPA signaling have demonstrated that LPA activates heterotrimeric G proteins, as well as small GTPases such as Rho that are positioned downstream in the signaling pathway (54) . Therefore, many of the initial signaling steps mediated by LPA are distinct from the RTK pathway. The presence of vzg-1 expression within the cerebral cortical vz indicates the existence of a specific role for heterotrimeric G protein signaling in cortical neurogenesis.
In view of vzg-1 expression in the zone of neuroblast proliferation, there is a possible role for mitogenic signaling mediated by LPA in cortical neuron generation. Mitogenic effects of LPA appear to involve activation of two signaling pathways. The PTX-sensitive pathway, involving activation of Gi and Ras (74, 76) , is probably mediated through [3~/snbunit signaling (21, 50, 51) . The PTX-insensitive pathway depends on functional Rho and might lead to cell proliferation through activation of a mitogen-activated protein kinase cascade (33, 35) . Functional Rho is also necessary for actin-based cytoskeletal changes (40, 61) . Our results directly demonstrate the activation of the PTX-sensitive Gi-linked pathway, and indirectly demonstrate the activation of the PTX-insensitive pathway leading to Rho activatio~n, by vzg-1 mediated LPA signaling in neocortical neuroblast cell lines. Thus, a single LPA receptor appears to mediate distinct signaling pathways. The possible interactions between RTK pathways and these G protein mediated events during cortical development will be addressed in future studies. Understanding these and related factors controlling cortical neurogenesis may provide new insights into the observed increase in cerebral cortical size with phylogenetic ascension. In addition to roles in neural development, this LPA receptor may participate in the functioning of many other developing and adult tissues and cell types, based on the diversity of effects known to be stimulated by LPA. Availability of a cDNA encoding a receptor for LPA should facilitate the molecular genetic characterization of LPA receptor-dependent interactions in various cell and tissue types and allow the development of agents that can be used to manipulate LPA receptor signaling pathways. The physiological consequences of LPA receptor elimination in mice, the sites of LPA production in vivo, and the possible role of this receptor in pathological states remain to be determined.
